Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity by Majumder, Biswanath, Baraneedharan, Ulaganathan, Thiyagarajan, Saravanan, Radhakrishnan, Padhma, Narasimhan, Harikrishna, Dhandapani, Muthu, Brijwani, Nilesh, Pinto, Dency D., Prasath, Arun, Shanthappa, Basavaraja U., Thayakumar, Allen, Surendran, Rajagopalan, Babu, Govind K., Shenoy, Ashok M., Kuriakose, Moni A., Bergthold, Guillaume, Horowitz, Peleg, Loda, Massimo, Beroukhim, Rameen, Agarwal, Shivani, Sengupta, Shiladitya, Sundaram, Mallikarjun, Majumder, Pradip K.

Get full text

Abstract 705: Nonuniform T-cell infiltration induced by PD-1 checkpoint blockade, ex vivo, predicts distinct clinical response by Smalley, Munisha, Shanthappa, Basavaraja, Gertje, Hans, Lawson, Mark, Ulaganathan, Baraneedharan, Thayakumar, Allen, Doval, D.C., Mehta, Anurag, Somashekhar, S. P., Radhakrishnan, Padhma, Majumder, Pradip, Goldman, Aaron J.

Get full text

Abstract LB-346: Case study: Non-uniform response to therapy in multiple metastatic is predicted using CANscriptTM, a live tissue, ex - vivo , platform by Ikpeazu, Chukwuemeka, Smalley, Munisha, Ulaganathan, Baraneedharan, Thayakumar, Allen, Majeiko, Laura, Ganesh, Jyothsana, Shanthappa, Basavaraja, Gertje, Hans, Lawson, Mark, Lapomarda, Sara, Goldman, Aaron

Get full text

Abstract 2835: Temporal sequencing of anticancer drugs, ex vivo , optimizes therapeutic effect by targeting drug-induced glucose-6-phosphate dehydrogenase by Ulaganathan, Baraneedharan, Dhawan, Andrew, Majumder, Biswanath, Smalley, Munisha, Thiyagarajan, Saravanan, Kodaganur, Gopinath S., Krishnamurthy, S, Rahman, Mohammed Mamunur, Freinkman, Elizaveta, Majumder, Pradip, Kohandel, Mohammad, Goldman, Aaron

Get full text

Abstract 2147: Generation of primary cell lines from advanced colon cancer: a tool for screening novel anticancer molecules by Nair, Rohini, Basu, Aninda, Dhandapani, Muthu, Majumder, Biswanath, Ulaganathan, Baraneedharan

Get full text

Abstract 1304: Identification of responders for Anti-CTLA4 in refractory colorectal cancers using CANScript™ platform by Majumder, Biswanath, Ulaganathan, Baraneedharan, Thayakumar, Allen, Thiyagarajan, Saravanan, Brijwani, Nilesh, Tewari, Biplab, Santhappa, Basavaraja U., Radhakrishnan, Padhma, Majumder, Pradip K.

Get full text

Abstract 3397: Intrinsic factors from patient's tumor help neovascularization in an ex vivo platform by Ulaganathan, Baraneedharan, Thayakumar B, Allen, Rajappa, Manoj, Velu, Ayyappan, Prasath, Arun, Ameer, Kamal, Brijwani, Nilesh, Radhakrishnan, Padhma, Majumder, Biswanath, Majumder, Pradip K., Thiyagarajan, Saravanan

Get full text

Low dose short duration pulsed electromagnetic field effects on cultured human chondrocytes: An experimental study by Anbarasan, Selvam, Baraneedharan, Ulaganathan, Paul, Solomon F. D., Kaur, Harpreet, Rangaswami, Subramoniam, Bhaskar, Emmanuel

Get full text

Abstract 3736: Application of patient tumors-derived tumor ecosystem platform for the development of novel HDAC inhibitor in solid cancers by Sundaram, Mallikarjun, Ulaganathan, Baraneedharan, Dhandapani, Muthu, Thayakumar, Allen, Mukhopadhyay, Pragnashree, Thiyagarajan, Saravanan, Majumder, Biswanath, Shivarudriah, Prasad, Jagadheshan, H, Sambasivam, Ganesh, Birnbuam, Steve, Radhakrishnan, Padhma, Majumder, Pradip K.

Get full text

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers by RADHAKRISHNAN, Padhma, BARANEEDHARAN, Ulaganathan, JAIN, Misti, BRIJWANI, Nilesh, NARAYANAN, Prasad, KEKATPURE, Vikram D, MAJUMDER, Biswanath, MAJUMDER, Pradip K, VELUCHAMY, Subhadra, DHANDAPANI, Muthu, PINTO, Dency D, THIYAGARAJAN, Saravanan, THAYAKUMAR, Allen, PRASATH, Arun, KAMAL, A, VELU, Ayyappan

Get full text

Bleomycin, neocarzinostatin and ionising radiation-induced bystander effects in normal diploid human lung fibroblasts, bone marrow mesenchymal stem cells, lung adenocarcinoma cells... by Chinnadurai, Mani, Chidambaram, Shravanthi, Ganesan, Venkateswaran, Baraneedharan, Ulaganathan, Sundaram, Lakshmi, Paul, Solomon F. D., Venkatachalam, Perumal

Get full text

Abstract 5072: Human tumor derived Oncoprint® platform predicts molecular mechanism of sensitivity and resistance to Fragmin in pancreatic cancer by Sundaram, Mallikarjun, Thiyagarajan, Saravanan, Dhandapani, Muthu, Brijwani, Nilesh, Prasath, Arun, Thayakumar, Allen, Kamal, Ameer, Radhakrishnan, Padhma, Majumder, Biswanath, Ulaganathan, Baraneedharan, Majumder, Pradip K.

Get full text

Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors by Radhakrishnan, Padhma, Dhandapani, Muthu, Ulaganathan, Baraneedharan, Thayakumar, Allen, Thiyagarajan, Saravanan, Pinto, Dency, Vinod, D R., Majumder, Biswanath, Shivarudriaah, Prasad, Jagadheshan, H, Sambasivam, Ganesh, Majumder, Pradip K.

Get full text

Abstract 4947: Inhibition of Rapamycin induced AKT activation elicits differential anti-tumor response in head and neck cancers by Radhakrishnan, Padhma, Baraneedharan, Ulaganathan, Dhandapani, Muthu, Thyakumar, Allen, Pinto, Dency, Prasath, Arun, Velu, Ayyappan, Kamal, A, Brijwani, Nilesh, Nair, Rohini, Basavaraja, R, Jain, Misti, Thiyagarajan, Saravanan, Majumder, Biswanath, Sundaram, Mallik, Narayanan, Prasad, Kekatpure, Vikram D., Majumder, Pradip K.

Get full text